Načítá se...

Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial()

BACKGROUND: Tramadol is an atypical analgesic with monoamine and modest mu opioid agonist activity. The purpose of this study was to evaluate: 1) the efficacy of extended-release (ER) tramadol in treating prescription opioid withdrawal and 2) whether cessation of ER tramadol produces opioid withdraw...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lofwall, Michelle R., Babalonis, Shanna, Nuzzo, Paul A., Siegel, Anthony, Campbell, Charles, Walsh, Sharon L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786049/
https://ncbi.nlm.nih.gov/pubmed/23755929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.05.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!